During the past decade, Baptist Health Medical Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Health Medical Group" #1 collaborator was "ARMO BioSciences" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Health Medical Group" are "Alzheimer's Disease" (2 trials), "Non Small Cell Lung Cancer" (2 trials), "Alzheimer Disease" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Mild Cognitive Impairment" (1 trials). Many other conditions were trialed in "Baptist Health Medical Group" in a lesser frequency.

Most popular intervention types in "Baptist Health Medical Group" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pegilodecakin" (2 trials), "Placebo" (2 trials), "Afatinib" (1 trials), "Florbetapir F 18 PET Scan" (1 trials) and "Lanabecestat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health Medical Group" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Baptist Health Medical Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Baptist Health Medical Group, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health Medical Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".